Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434355 · ClinicalTrials.gov registry record
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 932
- Enrollment target
NCT01434355: Completed study, sponsored by Children's Oncology Group.
NCT01434355 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 932 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01434355 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 932 participants
- Enrollment target
Study Summary
This research trial studies deoxyribonucleic acid (DNA) samples from younger patients with germ cell tumor and their parents or siblings. Studying samples of tumor tissue and saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Primary Outcome
Will be modeled using a Poisson regression. A likelihood ratio test determines the statistical significance.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 932 participants |
| Start Date | 2011-11-01 |
| Est. Completion | 2016-08-04 |
What the finished NCT01434355 record still lists
NCT01434355 is an observational study that tracks outcomes without assigning an intervention. The registered 932 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01434355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01434355 about?
NCT01434355 is a clinical study titled "DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings". This research trial studies deoxyribonucleic acid (DNA) samples from younger patients with germ cell tumor and their parents or siblings. Studying samples of tumor tissue and saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify b...
What is the current status of trial NCT01434355?
This trial is currently completed. The enrollment target is 932 participants. The study started on 2011-11-01. Estimated completion is 2016-08-04.
What interventions are being tested in trial NCT01434355?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT01434355?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04626635 · 933 participants · Phase 1
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
- NCT05216432 · 930 participants · Phase 1
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- NCT06932029 · 930 participants · NA
SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
- NCT07235085 · 930 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI